NKGen Biotech (NKGN) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free NKGN Stock Alerts $1.27 -0.02 (-1.55%) (As of 10:51 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media NKGen Biotech Stock Price Performance5 Day Performance-11.19%1 Month Performance+0.79%3 Month Performance-21.12%6 Month Performance-60.44%Year-To-Date Performance-53.82% Receive NKGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read NKGN Stock Chart for Wednesday, May, 8, 2024 NKGN Chart by TradingView NKGen Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.34$1.29-3.73%$1.33$1.28107,743 shs$29.03 million05/06/2024$1.43$1.34-6.29%$1.51$1.33128,292 shs$30.15 million05/03/2024$1.32$1.43+8.33%$1.55$1.32209,427 shs$32.18 million05/02/2024$1.46$1.32-9.59%$1.55$1.28244,201 shs$29.70 million05/01/2024$1.51$1.46-3.31%$1.53$1.42142,252 shs$33.30 million04/30/2024$1.64$1.51-7.93%$1.65$1.47439,593 shs$34.44 million Get the Latest News and Ratings for NKGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$1.61$1.64+1.86%$1.90$1.623.26 million shs$37.40 million04/26/2024$1.98$1.61-18.69%$1.95$1.60543,810 shs$36.72 million04/25/2024$1.71$1.98+15.79%$2.11$1.652.06 million shs$45.16 million04/24/2024$1.85$1.71-7.57%$1.96$1.611.44 million shs$39.01 million04/23/2024$1.47$1.85+25.85%$1.95$1.5211.49 million shs$42.20 million04/22/2024$1.11$1.47+32.91%$1.72$1.2023.62 million shs$33.53 million04/19/2024$0.86$1.11+28.60%$1.62$0.834.88 million shs$25.23 million04/18/2024$1.03$0.86-16.50%$1.02$0.82349,360 shs$18.83 million04/17/2024$1.21$1.03-14.88%$1.13$1.02182,059 shs$22.55 million04/16/2024$1.24$1.21-2.42%$1.25$1.2052,241 shs$26.49 million04/15/2024$1.20$1.24+3.33%$1.27$1.2085,157 shs$27.14 million04/12/2024$1.28$1.20-6.25%$1.31$1.2085,115 shs$26.27 million04/11/2024$1.26$1.28+1.59%$1.33$1.25432,380 shs$28.02 million04/10/2024$1.31$1.26-3.82%$1.30$1.2288,383 shs$27.58 million04/09/2024$1.26$1.31+3.97%$1.32$1.22115,027 shs$28.68 million04/08/2024$1.38$1.26-8.70%$1.31$1.20157,401 shs$27.58 million04/05/2024$1.28$1.38+7.81%$1.46$1.20215,164 shs$30.21 million04/04/2024$1.55$1.28-17.42%$1.60$1.28442,698 shs$28.02 million04/03/2024$1.82$1.55-14.84%$1.80$1.53284,519 shs$33.93 million04/02/2024$1.95$1.82-6.67%$1.94$1.81202,771 shs$39.84 million04/01/2024$1.89$1.95+3.17%$1.98$1.87159,383 shs$42.68 million03/29/2024$1.89$1.89$1.91$1.70395,893 shs$41.37 million03/28/2024$1.80$1.89+5.00%$1.91$1.70394,440 shs$41.37 million03/27/2024$1.92$1.80-6.25%$1.90$1.79471,817 shs$39.40 million03/26/2024$2.16$1.92-11.11%$2.15$1.83863,825 shs$42.03 million03/25/2024$2.32$2.16-6.90%$2.57$2.001.47 million shs$47.28 million03/22/2024$2.22$2.32+4.50%$2.54$2.211.43 million shs$50.79 million03/21/2024$2.19$2.22+1.37%$2.25$1.96831,386 shs$48.59 million03/20/2024$2.12$2.19+3.30%$2.47$2.131.85 million shs$47.94 million03/19/2024$1.97$2.12+7.61%$3.09$1.8722.03 million shs$46.41 million03/18/2024$1.96$1.97+0.51%$2.03$1.80561,962 shs$43.12 million03/15/2024$1.86$1.96+5.38%$2.05$1.76536,397 shs$42.90 million03/14/2024$1.97$1.86-5.58%$1.96$1.75328,409 shs$40.72 million03/13/2024$1.73$1.97+13.87%$2.09$1.78845,879 shs$43.12 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$2.56$1.73-32.42%$2.84$1.672.51 million shs$37.87 million03/11/2024$2.18$2.56+17.43%$3.10$2.239.78 million shs$56.04 million03/08/2024$1.93$2.18+12.95%$2.64$1.898.49 million shs$47.72 million03/07/2024$1.83$1.93+5.46%$2.35$1.7512.78 million shs$42.25 million03/06/2024$0.86$1.83+112.30%$4.06$1.16106.27 million shs$40.06 million03/05/2024$0.84$0.86+3.22%$0.99$0.85282,914 shs$18.87 million03/04/2024$0.85$0.84-1.64%$0.92$0.7887,254 shs$18.28 million03/01/2024$0.80$0.85+6.51%$0.85$0.8165,087 shs$18.59 million02/29/2024$0.80$0.80-0.37%$0.91$0.8047,989 shs$17.45 million02/28/2024$0.95$0.80-15.57%$0.99$0.80111,714 shs$17.51 million02/27/2024$0.97$0.95-2.08%$1.00$0.9511,721 shs$20.74 million02/26/2024$1.00$0.97-3.23%$1.04$0.9527,789 shs$21.18 million02/23/2024$1.00$1.00$1.00$0.9917,120 shs$21.89 million02/22/2024$0.95$1.00+5.22%$1.06$0.9936,993 shs$21.89 million02/21/2024$1.26$0.95-24.57%$1.27$0.94152,843 shs$20.80 million02/20/2024$1.50$1.26-16.00%$1.50$1.2565,961 shs$27.58 million02/19/2024$1.50$1.50$1.54$1.4815,300 shs$32.84 million02/16/2024$1.51$1.50-0.33%$1.54$1.4815,333 shs$32.84 million02/15/2024$1.51$1.51-0.33%$1.55$1.4813,902 shs$32.94 million02/14/2024$1.55$1.51-2.58%$1.64$1.4926,314 shs$33.05 million02/13/2024$1.62$1.55-4.32%$1.65$1.5214,483 shs$33.93 million02/12/2024$1.62$1.62$1.65$1.5914,403 shs$35.46 million02/09/2024$1.61$1.64+1.86%$1.66$1.6119,037 shs$35.90 million02/08/2024$1.58$1.61+1.90%$1.74$1.5716,712 shs$35.24 million02/07/2024$1.55$1.58+1.94%$1.59$1.557,681 shs$34.59 million Related Companies: Surrozen Stock Price Chart MiNK Therapeutics Stock Price Chart Protara Therapeutics Stock Price Chart IN8bio Stock Price Chart Estrella Immunopharma Stock Price Chart Achilles Therapeutics Stock Price Chart SAB Biotherapeutics Stock Price Chart Pluri Stock Price Chart Dyadic International Stock Price Chart Cyclo Therapeutics Stock Price Chart Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NKGN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.